Heritage Cannabis Holdings To Build 3.0 Million Square Feet Of Cannabis Grow Space In Clearview, Ontario

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

(TheNewswire)



Vancouver, B.C. / TheNewswire / February 1, 2018 – HERITAGE CANNABIS HOLDINGS CORPORATION (CSE: CANN) (“Heritage or Company”) is pleased to announce it has completed an accepted offer to acquire over 100 acres of farmland in Clearview Township, near Collingwood, Ontario.

 

Clearview is zoned agriculture and is approved for the cultivation of cannabis.  There are approximately 85 acres of flat usable land suited for both indoor and outdoor cultivation.  PhyeinMed Inc. (“PhyeinMed”), a Health Canada late stage applicant under the ACMPR (Access to Cannabis for Medical Purposes Regulations), has a long-term growth strategy, separated into multiple phases, ultimately culminating in an operation with growing capacity of 3,000,000 square feet, capable of producing in excess of 300,000 kilograms of cannabis per year.  The Company is anticipating a large demand for edibles and consumables, whether in candy or infused products, on legalization of this new market.  Since the product needed for this market has different characteristics than the current planned cannabis flower products the Company is looking to produce, it will be targeting a combination of indoor and outdoor growth in an effort to be a low-cost producer.

 

PhyeinMed anticipates it will complete its final submission for a licence to produce cannabis following Phase 1 completion in mid-February, and immediately after obtaining licence for the current site in Falkland, British Columbia, we will apply for a second site for the property located in Ontario herein referred to as the Clearview cannabis facility.

 

The agreement to acquire the property was made by 1005477 BC Ltd., a wholly owned subsidiary of Heritage, which also owns 75% of PhyeinMed.  Terms of the purchase include a total purchase price of $1.3 million with a targeted closing of June 30, 2018.  The offer includes many subjects to the benefit of the buyer, including the award of a Licence to Produce Cannabis.  The company will be providing a deposit of 10% of the purchase price immediately, with the remainder due at closing being paid by cash on hand.

 

Approval of the second site and licence permitting, construction is scheduled to begin in early 2019, with additional expansion to continue as demand grows.

 

“The expansion into Ontario is part of our long-term strategy of becoming a significant producer in the Canadian Cannabis marketplace.” commented Debra Senger, CEO of PhyeinMed “We are anticipating demand will outpace supply in the foreseeable future as legalization in Canada gets nearer to completion, and we intend to execute on our plan to ensure we can comfortably supply our customers with high quality products which will include all facets of the cannabis market for years to come”

 

About Heritage Cannabis Holdings Corporation

The Company is currently listed as a marijuana issuer having a 75% interest in PhyeinMed Inc, a Health Canada late stage applicant under the ACMPR (Access to Cannabis for Medical Purposes Regulations). It is a parent and development company with strategic plans to continue to acquire Cannabis related companies.

 

ON BEHALF OF THE BOARD OF DIRECTORS OF HERITAGE CANNABIS HOLDINGS CORPORATION

 

“Jag Bal”

 

Jagdip Bal

President and CEO

For more information contact:

Jag Bal

Tel:  604-628-1767

[email protected]       


The Canadian Stock Exchange does not accept responsibility for the adequacy or accuracy of this release.

 

This news release contains forward-looking information, which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectation. Important factors - including the availability of funds, the results of financing efforts, the results of exploration activities -- that could cause actual results to differ materially from the Company's expectations are disclosed in the Company's documents filed from time to time on SEDAR (see www.sedar.com). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

 


Click Image To View Full Size

 

Copyright (c) 2018 TheNewswire - All rights reserved.